Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Systematic Review

Published on 06 Jan 2025

Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: network meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Hui-Jun Li
Fu-Qiang Yin
Yu-Tong Ma
Teng-Yu Gao
Yu-Ting Tao
Xin Liu
Xian-Feng Shen
Chao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1462338

3,465 views
1 citation

Original Research

Published on 06 Jan 2025

Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter

in Gastrointestinal and Hepatic Pharmacology

Huiwen Yan
Dongdong Zhou
Xiaoli Liu
Peng Wang
Tingting Jiang
Zhiyun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449603

1,810 views
1 citation

Original Research

Published on 06 Jan 2025

Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology

in Gastrointestinal and Hepatic Pharmacology

Lisheng Chen
Xin Wang
Jianyu Li
Lijuan Zhang
Wenbin Wu
Shizhang Wei
Wenjun Zou
Yanling Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499753

6,108 views
6 citations

Systematic Review

Published on 03 Jan 2025

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis

in Gastrointestinal and Hepatic Pharmacology

Wenkai Zhang
Songbo Zhao
Jipin Li
Yihua Sun
Xiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481678

6,120 views
4 citations

Original Research

Published on 19 Dec 2024

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database

in Gastrointestinal and Hepatic Pharmacology

Ya-Jun Zhang
Dan-Dan Duan
Qian-Yu Tian
Cai-E. Wang
Shu-Xun Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1524903

3,748 views

Review

Published on 19 Dec 2024

Apigenin as an emerging hepatoprotective agent: current status and future perspectives

in Gastrointestinal and Hepatic Pharmacology

Cheng Wang
Xiaoli Feng
Wen Li
Li Chen
Xinming Wang
Yimiao Lan
Rong Tang
Ting Jiang
Lingli Zheng
Gang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508060

7,317 views
12 citations

Review

Published on 18 Dec 2024

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects

in Gastrointestinal and Hepatic Pharmacology

Wanqing Wang
Xue Liu
Lingling Zhao
Kaipeng Jiang
Ziyi Yu
Ruihan Yang
Wenshuo Zhou
Jiuwei Cui
Tingting Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505027

2,704 views
3 citations

Original Research

Published on 18 Dec 2024

Polysaccharides derived from golden mushroom (Cantharellus cibarius Fr.) modulate gut microbiota and enhance intestinal barrier function to ameliorate dextran sulfate sodium-induced colitis in mice

in Gastrointestinal and Hepatic Pharmacology

Yamina Alioui
Hidayat Ullah
Sharafat Ali
Mujeeb Ur Rahman
Maroua Elkharti
Nabeel Ahmed Farooqui
Ata Ur Rehman
Muhammad Ilyas
Duaa M. Alsholi
Nimra Zafar Siddiqi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498625

3,475 views
7 citations

Original Research

Published on 17 Dec 2024

Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway

in Gastrointestinal and Hepatic Pharmacology

Hang Chen
Minshan Huang
Dan Zhang
Hui Wang
Da Wang
Mengwei Li
Xianmei Wang
Rui Zhu
Jianjun Liu
Lanqing Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477212

2,606 views
3 citations

Editorial

Published on 13 Dec 2024

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

in Gastrointestinal and Hepatic Pharmacology

Isis Trujillo-Gonzalez
Paul G. Thomes
Isin Tuna Sakallioglu
Kusum K. Kharbanda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1529088

1,106 views
2 citations

Original Research

Published on 06 Dec 2024

Effect of Helicobacter pylori-related chronic gastritis on gastrointestinal microorganisms and brain neurotransmitters in mice

in Gastrointestinal and Hepatic Pharmacology

Hai-Hua Liu
Tang-Tang Lin
Qi-Jia Zhang
Ling Zhang
Jin-Ying Fang
Ling Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472437

1,960 views
1 citation

Editorial

Published on 04 Dec 2024

Editorial: The roles of pathogens in gut-related diseases and the strategies for inhibiting their growth

in Gastrointestinal and Hepatic Pharmacology

Imran Khan
Huang Gouxin
Shafia Khan
Abid Ali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1513694

1,717 views
1 citation

Original Research

Published on 02 Dec 2024

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

in Gastrointestinal and Hepatic Pharmacology

Nevertyty Mohamed Mahmoud
Shimaa M. Elshazly
Fatma El-shaarawy
Sawsan A. Zaitone
Afaf A. Aldahish
Gehan A. Ahmed
Manal S. Fawzy
Sheka Yagub Aloyouni
Sally Y. Abed
Tahani Saeedi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491249

2,779 views
1 citation

Review

Published on 28 Nov 2024

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

in Gastrointestinal and Hepatic Pharmacology

Xiao Hong
Shuo Huang
He Jiang
Qing Ma
Jiang Qiu
Qihan Luo
Chunlu Cao
Yiyang Xu
Fuzhe Chen
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432480

10,778 views
20 citations

Original Research

Published on 25 Nov 2024

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

in Gastrointestinal and Hepatic Pharmacology

Zhiyuan Zhang
Yifan Yao
Li Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500810

3,246 views
5 citations

Original Research

Published on 25 Nov 2024

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

in Gastrointestinal and Hepatic Pharmacology

Johnny Amer
Ahmad Salhab
Enas Hussini
Rasha Shweiki
Iman Zahran
Mohammad Far

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484278

2,455 views
1 citation

Original Research

Published on 22 Nov 2024

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

in Gastrointestinal and Hepatic Pharmacology

Meng Liu
Yuhui Wang
Xiaotian Xu
Guoqiang Guan
Shu Zhang
Shengnan Zhu
Yang Liu
Yizhun Zhu
Xiaoqun Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448863

3,971 views
3 citations

Original Research

Published on 21 Nov 2024

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

in Gastrointestinal and Hepatic Pharmacology

Li Song
Shuo Huang
Honghao Yan
Qing Ma
Qihan Luo
Jiang Qiu
Minxia Chen
Zongyuan Li
He Jiang
Yufan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423031

3,605 views
1 citation

Original Research

Published on 20 Nov 2024

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

in Gastrointestinal and Hepatic Pharmacology

Tekleab Teka
Jiang Wu
Patrick Kwabena Oduro
Ze Li
Chenxi Wang
Hao Chen
Lin Zhang
Haitao Wang
Liming Wang
Lifeng Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485035

2,664 views

Original Research

Published on 13 Nov 2024

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

in Gastrointestinal and Hepatic Pharmacology

Andy Wai Kan Yeung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498464

2,156 views
2 citations

Original Research

Published on 13 Nov 2024

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

in Gastrointestinal and Hepatic Pharmacology

Hui Guo
Qian Guo
Zhiqiang Li
Ze Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461398

12,064 views
15 citations

Original Research

Published on 08 Nov 2024

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Szilvia B. László
Barbara Hutka
András S. Tóth
Tamás Hegyes
Zsuzsanna O. Demeter
Arezoo Haghighi
Gerda Wachtl
Ágnes Kelemen
Anna Jakab
Klára Gyires

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468579

2,522 views
3 citations

Clinical Trial

Published on 08 Nov 2024

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

in Gastrointestinal and Hepatic Pharmacology

Eman Mohamed Elmokadem
Dina Khaled Abou El Fadl
Nermin Eissa
Najla Abdulaziz Alnassar
Ahmed M. Bassiouny
Amir Eskander Hanna Samy
Nouran Omar El Said

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413246

3,705 views

Original Research

Published on 07 Nov 2024

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis

in Gastrointestinal and Hepatic Pharmacology

Jing Xie
Xinhua Liang
Fangfang Xie
Canxin Huang
Zijun Lin
Shuping Xie
Fangying Yang
Fengfeng Zheng
Lanlan Geng
Wanfu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409001

3,042 views
5 citations

1,288 articles

articles

Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: network meta-analysis

Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter

Elucidation of the mechanism of berberine against gastric mucosa injury in a rat model with chronic atrophic gastritis based on a combined strategy of multi-omics and molecular biology

Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database

Apigenin as an emerging hepatoprotective agent: current status and future perspectives

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects

Polysaccharides derived from golden mushroom (Cantharellus cibarius Fr.) modulate gut microbiota and enhance intestinal barrier function to ameliorate dextran sulfate sodium-induced colitis in mice

Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Effect of Helicobacter pylori-related chronic gastritis on gastrointestinal microorganisms and brain neurotransmitters in mice

Editorial: The roles of pathogens in gut-related diseases and the strategies for inhibiting their growth

Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

Osteopontin neutralization increases vitamin D receptors on NKT cells and ameliorates liver fibrosis by promoting their activity

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation

Integrated multi-omics analyses combined with western blotting discovered that cis-TSG alleviated liver injury via modulating lipid metabolism

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats

Comparison of enteral prucalopride versus intravenous metoclopramide for feeding intolerance in patients with critical illness: a randomized double-blinded study

Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis